Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

BMS pays $475m for Dragonfly’s IL-12 immunotherapy programme

BMS pays $475m for Dragonfly’s IL-12 immunotherapy programme As well as testing the drug as a mono therapy, Dragonfly is also studying DF6002 in combination with PD-1 inhibiting treatment, such as BMS’ Opdivo (nivolumab).

Bristol-Myers Squibb’s revenues rise on Celgene acquisition

Bristol-Myers Squibb’s revenues rise on Celgene acquisition Sales of immunotherapy Opdivo decreased due to COVID-19 impact. Bristol-Myers Squibb has posted better-than-expected results in the second quarter of the year, with shares in the company ... One concerning caveat among the otherwise positive results was

Roche’s Tecentriq combo scores FDA approval for melanoma

Roche’s Tecentriq combo scores FDA approval for melanoma However, Roche is likely to face fierce competition from rival checkpoint inhibitors, namely Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo which have already been on the market ... Opdivo, on the other hand, was first

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer

NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer number of cancer immunotherapies including Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab).

BMS suspends new clinical trials as COVID-19 cases rise in US

BMS suspends new clinical trials as COVID-19 cases rise in US Both of those are also under review in Europe. Following after is an FDA review of checkpoint inhibitor combination Opdivo (nivolumab) and Yervoy (ipilimumab) in first-line non-small cell lung

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics